Seqens Seqens

X

Find the latest Drugs in Development and Pipeline Prospector News of ConvaTec.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
ConvaTec
unitedkingdom_new Flag
Country
Country
United Kingdom
Address
Address
7th Floor, 20 Eastbourne Terrace, London, W2 6LG
Telephone
Telephone
1 800339412
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

The divestment will allow 30 Technology to accelerate its ultra-broad spectrum NO-generation and rapidly advance its innovative and differentiated platform of NO-generating technologies, including RESP301, a NO-generating liquid designed to release NO in situ.


Lead Product(s): RESP301

Therapeutic Area: Genetic Disease Product Name: RESP301

Highest Development Status: Phase IIProduct Type: Small molecule

Recipient: 30 Technology

Deal Size: $218.0 million Upfront Cash: $55.9 million

Deal Type: Divestment April 19, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY